Both in Pharmaceuticals
Jade Biosciences vs MoonLake Immunotherapeutics
Over the past year JBIO returned +50.8% and MLTX returned +16.3%; their daily moves had a correlation of 0.25.
JBIO +50.8% MLTX +16.3%Growth of $1, one year, split-adjusted
| Metric | JBIO | MLTX |
|---|---|---|
| Price | $15.13 | $10.65 |
| Market cap | $962.2M | $906.4M |
| Today | +1.82% | +3.20% |
| 1 month | −9.7% | −20.4% |
| 6 months | −40.4% | −38.2% |
| Year to date | −1.9% | −19.2% |
| 1 year | +51.3% | +13.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $461.2M | $437.5M |
| Dividend yield | — | — |
| Volatility (60d) | 57.5% | 48.7% |
| Short % of float | 22.4% | 14.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).